Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Respiratory Medicine|November 8, 2022
Impact of reduction in antifibrotic treatment on mortality in idiopathic pulmonary fibrosisSimon Porse, Nils Hoyer, Saher B ShakerMalaria Journal|June 3, 2014
Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparumCasper Hempel, Nils Hoyer, Trine Staalsø, et al.BMJ Open Respiratory Research|July 7, 2022
Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation ratesNils Hoyer, Thomas Skovhus Prior, Elisabeth Bendstrup, et al.Respiratory Research|May 26, 2019
Risk factors for diagnostic delay in idiopathic pulmonary fibrosisNils Hoyer, Thomas Skovhus Prior, Elisabeth Bendstrup, et al.Frontiers in Immunology|July 5, 2014
Systemic and Cerebral Vascular Endothelial Growth Factor Levels Increase in Murine Cerebral Malaria along with Increased Calpain and Caspase Activity and Can be Reduced by Erythropoietin TreatmentCasper Hempel, Nils Hoyer, Anna Kildemoes, et al.Respiratory Research|April 23, 2020
Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosisThomas Skovhus Prior, Nils Hoyer, Ole Hilberg, et al.Respiratory Research|October 6, 2021
Validation of a derived version of the IPF-specific Saint George's Respiratory QuestionnaireThomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, et al.Respiratory Research|August 30, 2019
Validation of the IPF-specific version of St. George's Respiratory QuestionnaireThomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, et al.Respiratory Medicine|June 15, 2021
Clusters of comorbidities in idiopathic pulmonary fibrosisThomas Skovhus Prior, Nils Hoyer, Ole Hilberg, et al.Pageof 3